Clinical trial
Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients
NCT00069498 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00069498 |
|---|---|
| Title | Effect of an Anti-Inflammatory Drug on Gut Mucosa in HIV Infected Patients |
| Official title | Impact of Co-Receptor and HIV Viral Burden on Gut Mucosa |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | 5-aminosalicylic acid |
| Enrollment | 14 |
| Start date | Oct 1, 1999 |
| First posted | Sep 30, 2003 |
| Last update posted | May 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: